Met primary endpoints for phase 2 trials. Fully funded. Orphan drug status. Backed by Twiggy.
Yet since market announcement of Phase 2 completion, this stock has sunk and sunk and sunk. Originally I assumed profit take from the capital raise, but now I question;
Has the story changed? Is there something I'm missing?
Met primary endpoints for phase 2 trials. Fully funded. Orphan...
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.012M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28219 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.6¢ | 2202 | 1 |
View Market Depth
| Last trade - 16.12pm 03/05/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable